Recent data [98] have shown that silibinin is able to restore the levels of phosphorylated IRS-1, total IRS-1, PI3K, and phosphorylated Akt, which are inhibited in NAFLD. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.